Impact of obesity on the clinical profile of a population-based sample with chronic obstructive pulmonary disease

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Garciá Rio, Francisco ^a,b   Soriano, Joan B ^b,c   Miravitlles, Marc ^d   Munõz, Luis ^e   Duran Tauleria, Enric ^f   Sańchez, Guadalupe ^g   Sobradillo, Victor ^h   Ancochea, Julio ⁱ  

^a HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c CIBER de Enfermedades Respiratorias   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^e HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^f CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^g GLAXOSMITHKLINE   (Spain)

^h HOSPITAL DE CRUCES   (Spain)

ⁱ HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; C REACTIVE PROTEIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; FIBRINOGEN; INTERLEUKIN 6; INTERLEUKIN 8; METHYLXANTHINE DERIVATIVE; NITRATE; NITRITE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER;

6 MINUTE WALK TEST; ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHARLSON COMORBIDITY INDEX; CHRONIC BRONCHITIS; CHRONIC COUGH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC PHLEGM; COMORBIDITY; CONTROLLED STUDY; DYSPNEA; EUROQOL 5 DIMENSIONS QUESTIONNAIRE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEALTH STATUS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RESPIRATORY AIRFLOW; RESPIRATORY TRACT DISEASE; SMOKING HABIT; SPIROMETRY; ST. GEORGE RESPIRATORY QUESTIONNAIRE; UNDERWEIGHT; VISUAL ANALOG SCALE; WALKING SPEED; WHEEZING; COMPLICATION; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RISK; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BODY MASS INDEX; FEMALE; HUMANS; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RISK FACTORS;

EID: 84929451271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105220     Document Type: Article

References (44)

1. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (Revised 2011). Available: http://www.goldcopd.org. Accessed: 2014 Apr 2.
2. Task Force for GesEPOC (2012) Clinical practice guideline for the diagnosis and treatment of patients with chronic obstructive pulmonary disease (COPD) - Spanish guideline for COPD (GesEPOC). Arch Bronconeumol 48 (Suppl 1): 2-58.
3. Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ (2008) Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 5: 549-555. (Pubitemid 351669185)
4. Schols AM, Slangen J, Volovics L, Wouters EF (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1791-1797.
5. Bernard S, Leblanc P, Whittom F, Carrier G, Jobin J, et al. (1998) Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 158: 629-634. (Pubitemid 28378196)
6. Landbo Ch, Prescott E, Lange P, Vestbo J, Almdal TP (1999) Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 160: 1856-1861. (Pubitemid 30004687)
7. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012. (Pubitemid 38269277)
8. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA (2002) The relation of body mass index to asthma, chronic bronchitis, and emphysema. Chest 122: 1256-1263. (Pubitemid 35339538)
9. García Rodríguez LA, Wallander MA, Tolosa LB, Johansson S (2009) Chronic obstructive pulmonary disease in UK primary care: incidence and risk factors. COPD 6: 369-379.
10. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, et al. (1993) Prevalence and characteristics of nutricional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 147: 1151-1156. (Pubitemid 23149871)
11. Gray-Donald K, Gibbons L, Shapiro SH, Macklem PT, Martin JG (1996) Nutritional status and mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 153: 961-966. (Pubitemid 26081646)
12. Chailleux E, Laaban JP, Veale D (2003) Prognostic value of nutritional depletion in patients with COPD treated by long-term oxygen therapy: data from the ANTADIR observatory. Chest 123: 1460-1466. (Pubitemid 36549763)
13. Montes de Oca M, Tálamo C, Perez-Padilla R, Jardim JRB, Muiño A, et al. (2008) Chronic obstructive pulmonary disease and body mass index in five Latin America cities: The PLATINO study. Respir Med 102: 642-650.
14. Vozoris NT, O'Donnell DE (2012) Prevalence, risk factors, activity limitation and health care utilization of an obese population-based sample with chronic obstructive pulmonary disease. Can Respir J 19: e18-e24.
15. Ancochea J, Badiola C, Duran E, García Río F, Miravitlles M, et al. (2009) Estudio EPI-SCAN: resumen del protocolo de un estudio para estimar la prevalencia de EPOC en personas de 40 a 80 años de edad en España. Arch Bronconeumol 45: 41-47.
16. Miravitlles M, Soriano JB, García-Río F, Muñoz L, Duran-Taulería E, et al. (2009) Prevalence of COPD in Spain: Impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64: 863-868.
17. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, et al. (2005) Standardisation of spirometry. Eur Respir J 26: 319-338. (Pubitemid 41079078)
18. World Health Organization (1995) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 854: 1-452.
19. García-Río F, Miravitlles M, Soriano JB, Muñoz L, Duran-Tauleria E, et al. (2010) Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 11: 63.
20. ATS Statement: Guidelines for the six-minute walk test (2002) Am J Respir Crit Care Med 166: 111-116.
21. Puham MA, Garcia-Aymerich J, Frey M, Riet G, Antó JM, et al. (2009) Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet 374: 704-711.
22. Cecere LM, Littman AJ, Slatore CG, Udris EM, Bruson CL, et al. (2011) Obesity and COPD: associated symptoms, health-related quality of life, and medication use. COPD 8: 275-284.
23. O'Donnel DE, Deesomchok A, Lam YM, Guenette JA, Amornputtisathaporn N, et al. (2011) Effects of BMI on static lung volumes in patients with airway obstruction. Chest 140: 461-468.
24. Čekerevac I, Lazić Z (2011) Obesity and chronic obstructive pulmonary disease. Srp Arh Celok Lek 139: 322-327.
25. Rennard SI, Calverley P (2003) Rescue! Therapy and the paradox of the Barcalounger. Eur Respir J 21: 916-917. (Pubitemid 36675603)
26. Van den Bemt L, van Wayenburg CAM, Smeele IJM, Schermer TRJ (2009) Obesity in patients with COPD, an undervalued problem?. Thorax 64: 640.
27. Franssen FME, O'Donnell DE, Goossens GH, Blaak EE, Schols AMWJ (2008) Obesity and the lung: 5-Obesity and COPD. Thorax 63: 1110-1117.
28. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, et al. (2009) Combined effects of obesity and chronic obstructive pulmonary disease and exercise tolerance. Am J Respir Crit Care Med 180: 964-971.
29. Salome CM, Munoz PA, Berend N, Thorpe CW, Schachter LM, et al. (2008) Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. Int J Obes (Lond) 32: 502-509. (Pubitemid 351414819)
30. Deesomchok A, Fisher T, Webb KA, Ora J, Lam YM, et al. (2010) Effects of obesity on perceptual and mechanical responses to bronchoconstriction in asthma. Am J Respir Crit Care Med 181: 125-133.
31. Shim YM, Burnette A, Lucas S, Herring RC, Weltman J, et al. (2013) Physical deconditioning as a cause of breathlessness among obese adolescents with a diagnosis of asthma. PLoS ONE 8: e61022.
32. Miravitlles M, Soriano JB, Ancochea J, Muñoz L, Duran-Tauleria E, et al. (2013) Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med 107: 1053-1060.
33. Ischaki E, Papatheodorou G, Gaki E, Papa I, Koulouris N, et al. (2007) Body mass and fat-free mass indices in COPD. Relation with variables expressing disease severity. Chest 132: 164-169. (Pubitemid 47068217)
34. Laviolette L, Sava F, O'Donnell DE, Webb KA, Hamilton AL, et al. (2010) Effect of obesity on constant work rate exercise in hyper inflated men with COPD. BMC Pulm Med 10: 33.
35. Lavie CJ, Milani RV (2003) Obesity and cardiovascular disease: the Hippocrates paradox? J Am Coll Cardiol 42: 677-679. (Pubitemid 37000184)
36. Garcia-Aymerich J, Gomez FP, Benet M, Farrero E, Basagaña X, et al. (2011) Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 66: 430-437.
37. Mannino DM, Doherty DE, Buist S (2006) Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the atherosclerosis risk in communities (ARIC) study. Respir Med 100: 115-122. (Pubitemid 43039873)
38. Nicholas R, Anthonisen MD, Melissa A, Skeans MS, Wise MD, et al. (2005) The effects of a smoking cessation intervention on 14.5-year mortality. Ann Intern Med 142: 233-239.
39. Cao C, Wang R, Wan J, Bunjhoo H, Xu Y, et al. (2012) Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS ONE 7: e43892.
40. Jordan JG Jr, Mann JR (2010) Obesity and mortality in persons with obstructive lung disease using data from the NHANES III. South Med J 103: 323-330.
41. Figarska SM, Boezen HM, Vonk JM (2012) Dyspnea severity, changes in dyspnea status and mortality in the general population: the Vlagtwedde/ Vlaardingen study. Eur J Epidemiol 27: 867-876.
42. Broekhuizen R, Wouters EF, Creutzberg EC, Schols AM (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61: 17-22. (Pubitemid 43106972)
43. Sin DD, Man SF (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? the potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107: 1514-1519. (Pubitemid 36378490)
44. Fabbri LM, Rabe KF (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 370: 797-799. (Pubitemid 47320803)